Table 2 Baseline characteristics of COPD and asthma patients
Severity | Disease courses | Sex‡ | Age (yr) | BMI | Smoking history (pack years) | FEV1/FVC | FEV1 predicted | |
|---|---|---|---|---|---|---|---|---|
M | F | |||||||
COPD* | ||||||||
GOLD II | 12.9 ± 11.2 | 10 | 2 | 69.7 ± 9.0 | 22.6 ± 4.6 | 27.5 ± 30.7 | 0.64 ± 0.1 | 0.63 ± 0.1 |
GOLD III | 17.5 ± 14.7 | 21 | 0 | 73.6 ± 9.2 | 22.2 ± 3.4 | 33.0 ± 18.7 | 0.50 ± 0.1 | 0.39 ± 0.0 |
GOLD IV | 13.6 ± 9.0 | 8 | 2 | 72.0 ± 6.5 | 19.9 ± 3.1 | 25.0 ± 17.1 | 0.54 ± 0.1 | 0.34 ± 0.2 |
Asthma† | ||||||||
GINA I | 1.5 ± 1.3 | 1 | 4 | 50 ± 19.4 | 22.4 ± 2.7 | 0 ± 0 | 0.70 ± 0.2 | 0.74 ± 0.2 |
GINA II | 12.9 ± 15.8 | 8 | 12 | 51.2 ± 11.3 | 23.4 ± 5.0 | 5.2 ± 1.3 | 0.67 ± 0.3 | 0.83 ± 0.3 |
GINA III | 17.8 ± 13.7 | 9 | 13 | 46.3 ± 17.8 | 22.7 ± 2.8 | 22.2 ± 6.7 | 0.65 ± 0.2 | 0.68 ± 0.3 |
GINA IV | 11.7 ± 7.1 | 5 | 5 | 55.7 ± 18.2 | 22.7 ± 2.8 | 21.2 ± 10.1 | 0.63 ± 0.2 | 0.69 ± 0.2 |